Management of Axial Spondyloarthritis – Insights into Upadacitinib by Braun J, Kiltz U, Baraliakos X

Get full text

Magnetic resonance imaging characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIMISE cohort by Baraliakos, X, Pournara, E, Coates, LC, Navarro-Compán, V, Blanco, R, O’Brien, E, Schulz, B, Landewe, R

Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases by Taylor, PC, Choy, E, Baraliakos, X, Szekanecz, Z, Xavier, RM, Isaacs, JD, Strengholt, S, Parmentier, JM, Lippe, R, Tanaka, Y

Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOS by Gossec, L, Baraliakos, X, Aletaha, D, Sharaf, M, Rampakakis, E, Lavie, F, López-Medina, C, Selmi, C, Coates, LC

Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial by Baraliakos, X, Pournara, E, Gossec, L, Mease, P, White, R, O’Brien, E, Schulz, B, Marzo Ortega, H, Coates, LC

Secukinumab demonstrates high and sustained efficacy in nail psoriasis: Post hoc analysis from phase 3 trials in patients with psoriatic arthritis by Reich, K, Baraliakos, X, Coates, LC, Elewski, B, Bao, W, Kasparek, T, Gaillez, C, Pournara, E, Aassi, M, Perella, C, Gottlieb, AB

Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial by Baraliakos, X, Gossec, L, Pournara, E, Jeka, S, Varela, AM, D’Angelo, S, Schulz, B, Rissler, M, Nagar, K, Perella, C, Coates, LC

Secukinumab provides sustained improvements in clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations: results from the MAXIMISE trial by Baraliakos, X, Gossec, L, Pournara, E, Jeka, S, Blanco, R, D'Angelo, S, Schett, G, Schulz, B, Rissler, M, Whyms, D, Perella, C, Coates, LC

Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies by Baraliakos, X, Ranza, R, Östör, A, Ciccia, F, Coates, LC, Rednic, S, Walsh, JA, Douglas, K, Gao, T, Kato, K, Song, I-H, Ganz, F, Deodhar, A

EARLY EFFECT OF SECUKINUMAB IN REDUCING SPINAL INFLAMMATION AS DETECTED BY MAGNETIC RESONANCE IMAGING IN PATIENTS WITH ANKYLOSING SPONDYLITIS by Van Laar, J, Baraliakos, X, Braun, J, Laurent, D, Baeten, D, van der Heijde, D, Sieper, J, Emery, P, McInnes, I, Landewe, R, Wordsworth, B, Wollenhaupt, J, Kellner, H, Wright, A, Gsteiger, S, Hueber, W

Interleukin-17A Blockade with Secukinumab Reduces Spinal Inflammation in Patients with Ankylosing Spondylitis As Early As Week 6, As Detected by Magnetic Resonance Imaging by Baraliakos, X, Braun, J, Laurent, D, Baeten, D, van der Heijde, D, Sieper, J, Emery, P, McInnes, I, van Laar, J, Landewe, R, Wordsworth, P, Wollenhaupt, J, Kellner, H, Wright, A, Gsteiger, S, Hueber, W

LONG TERM INHIBITION OF IL-17A WITH SECUKINUMAB REDUCES SPINAL INFLAMMATION BUT HAS NO INFLUENCE ON FATTY LESIONS AS ASSESSED BY MAGNETIC RESONANCE IMAGING IN PATIENTS WITH ANKYLOS... by Baraliakos, X, Braun, J, Laurent, D, Baeten, D, van der Heijde, D, Sieper, J, Emery, P, McInnes, I, van Laar, J, Landewe, R, Wordsworth, P, Wollenhaupt, J, Kellner, H, Wright, A, Vandenhende, F, Radford, K, Borah, B, Hueber, W

Long term IL-17A inhibition by secukinumab leads to reduced spinal inflammation and unchanged fatty lesions in patients with ankylosing spondylitis by Baraliakos, X, Braun, J, Laurent, D, Baeten, D, van der Heijde, D, Sieper, J, Emery, P, McInnes, I, van Laar, J, Landewe, R, Wordsworth, P, Wollenhaupt, J, Kellner, H, Wright, A, Vandenhende, F, Radford, K, Borah, B, Hueber, W

Long Term Inhibition of Interleukin (IL)-17A with Secukinumab Improves Clinical Symptoms and Reduces Spinal Inflammation As Assessed by Magnetic Resonance Imaging in Patients with... by Baraliakos, X, Braun, J, Laurent, D, Baeten, D, van der Heijde, D, Sieper, J, Emery, P, McInnes, I, van Laar, J, Landewe, R, Wordsworth, P, Wollenhaupt, J, Kellner, H, Wright, A, Vandenhende, F, Radford, K, Borah, B, Wolfgang, H

The phenotype of axial spondyloarthritis: is it dependent on HLA‐B27 status? by Coates, LC, Baraliakos, X, Blanco Garcia, F, Blanco-Morales, E, Braun, J, Chandran, V, Fernandez-Sueiro, JL, FitzGerald, O, Gallagher, P, Gladman, DD, Gubar, E, Korotaeva, T, Loginova, E, Lubrano, E, Mulero, J, Pinto, J, Queiro, R, Sanz, J, Szentpetery, A, Helliwell, PS

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. by Baeten, D, Baraliakos, X, Braun, J, Sieper, J, Emery, P, van der Heijde, D, McInnes, I, van Laar, J, Landewé, R, Wordsworth, P, Wollenhaupt, J, Kellner, H, Paramarta, J, Wei, J, Brachat, A, Bek, S, Laurent, D, Li, Y, Wang, Y, Bertolino, A, Gsteiger, S, Wright, A, Hueber, W

Eular recommendations for the use of imaging in mechanical low back pain by Hansen, B, Terslev, L, Berenbaum, F, Möller, I, Boesen, M, Laredo, J, Rannou, F, Lohmander, S, Englund, M, Baraliakos, X, Conaghan, P, Genevay, S, Palazzo, C, Wilson, D, Wilkie, R, Prieto-Alhambra, D, Kent, A, Makri, S, Navarro Compán, V, Nguyen, C, Bartels, M, Nordberg, C, D'Agostino, A, Fournier, G, Fournier, G, Force, E

Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Resear... by Poddubnyy, D, Baraliakos, X, Van den Bosch, F, Braun, J, Coates, LC, Chandran, V, Diekhoff, T, van Gaalen, FA, Gensler, LS, Goel, N, Gottlieb, AB, van der Heijde, D, Helliwell, PS, Hermann, KGA, Jadon, D, Lambert, RG, Maksymowych, WP, Mease, P, Nash, P, Proft, F, Protopopov, M, Sieper, J, Torgutalp, M, Gladman, DD

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force by Smolen, JS, Schöls, M, Braun, J, Dougados, M, FitzGerald, O, Gladman, DD, Kavanaugh, A, Landewé, R, Mease, P, Sieper, J, Stamm, T, Wit, MD, Aletaha, D, Baraliakos, X, Betteridge, N, Bosch, FVD, Coates, LC, Emery, P, Gensler, LS, Gossec, L, Helliwell, P, Jongkees, M, Kvien, TK, Inman, RD, McInnes, IB, Maccarone, M, Machado, PM, Molto, A, Ogdie, A, Poddubnyy, D, Ritchlin, C, Rudwaleit, M, Tanew, A, Thio, B, Veale, D, Vlam, KD, van der Heijde, D